Patterns of Initial Antidementia Medication Prescriptions Among Community-Dwelling Individuals in Norway: A Comprehensive Register-Based Analysis - Report - MDSpire
Advertisement
Patterns of Initial Antidementia Medication Prescriptions Among Community-Dwelling Individuals in Norway: A Comprehensive Register-Based Analysis
Patterns of Initial Antidementia Medication Prescriptions in Norway
Overview
This study analyzes trends in the incidence rates of antidementia drug prescriptions among community-dwelling individuals aged 60 and older in Norway from 2006 to 2020. It highlights a decline in the proportion of prescriptions initiated by general practitioners over time, particularly among older individuals and females.
Background
Dementia is a growing global health concern, particularly as populations age, leading to increased healthcare demands. In Norway, a significant number of individuals with dementia live at home, making the role of general practitioners crucial in the management and treatment of this condition. Understanding prescription patterns is essential for improving dementia care and ensuring appropriate treatment initiation.
Data Highlights
The study utilized data from the Norwegian Prescribed Drug Registry to assess antidementia drug dispensations from 2006 to 2020.
Key Findings
The annual incidence rate of antidementia drug dispensations declined throughout the study period.
Older individuals and females were more likely to receive their first antidementia drug dispensation from a GP compared to younger individuals and males.
The proportion of first-time antidementia drugs prescribed by GPs decreased over time for both genders.
There is a need for further research into barriers affecting GP involvement in prescribing antidementia medications.
Population-based studies on antidementia medication prescriptions are limited, particularly for home-dwelling individuals.
Clinical Implications
The findings suggest a potential shift in the initiation of antidementia medications away from general practitioners, which may impact patient access to treatment. Addressing barriers to GP involvement is essential for optimizing dementia care and ensuring timely treatment initiation.
Conclusion
The decline in GP-prescribed antidementia medications raises important questions about the role of primary care in dementia management. Further investigation is needed to understand the factors influencing these prescribing patterns.
